References
- Uhrich KE, Cannizzaro SM, Langer RS, et al. Polymeric systems for controlled drug release. Chem Rev. 1999;99: 3181–3198.
- Hirayama F, Uekama K. Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev. 1999;36:125–141.
- MuÈller RH, MaÈder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161–177.
- Freiberg S, Zhu X. Polymer microspheres for controlled drug release. Int J Pharm. 2004;282:1–18.
- Yao X, Niu X, Ma K, et al. Graphene quantum dots‐capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy. Small. 2017;13(2):1602225. doi: 10.1002/smll.201602225
- Slowing II, Vivero-Escoto JL, Wu C-W, et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev. 2008;60: 1278–1288.
- Joo SH, Park JY, Tsung C-K, et al. Thermally stable Pt/mesoporous silica core-shell nanocatalysts for high-temperature reactions. Nat Mater. 2009;8:126.
- Wu L, Jiao Z, Wu M, et al. Formation of mesoporous silica nanoparticles with tunable pore structure as promising nanoreactor and drug delivery vehicle. RSC Adv. 2016;6:13303–13311.
- Lu J, Liong M, Li Z, et al. Biocompatibility, biodistribution, and drug‐delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small. 2010;6: 1794–1805.
- Giri S, Trewyn BG, Stellmaker MP, et al. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed Engl. 2005;44:5038–5044.
- Trewyn BG, Slowing II, Giri S, et al. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc Chem Res. 2007;40:846–853.
- Hu X, Wang Y, Peng B. Chitosan‐capped mesoporous silica nanoparticles as pH‐responsive nanocarriers for controlled drug release. Chem Asian J. 2014;9:319–327.
- de la Torre C, Mondragón L, Coll C, et al. Cathepsin‐B induced controlled release from peptide‐capped mesoporous silica nanoparticles. Chem Eur J. 2014;20:15309–15314.
- Peng H, Dong R, Wang S, et al. A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly (acrylic acid) shell-layers: fabrication, characterization and properties for controlled release of salidroside. Int J Pharm. 2013;446:153–159.
- Yang K-N, Zhang C-Q, Wang W, et al. pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment. Cancer Biol Med. 2014;11:34.
- Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov. 2014;13:813.
- Zhu L, Torchilin VP. Stimulus-responsive nanopreparations for tumor targeting. Integrative Biol. 2013;5:96–107.
- Engin K, Leeper D, Cater J, et al. Extracellular pH distribution in human tumours. Int J Hyperthermia. 1995;11: 211–216.
- Lee ES, Oh KT, Kim D, et al. Tumor pH-responsive flower-like micelles of poly(l-lactic acid)-b-poly(ethylene glycol)-b-poly(l-histidine)). J Control Release. 2007;123:19–26.
- Yang JM, Huang MJ, Yeh TS. Preparation of poly (acrylic acid) modified polyurethane membrane for biomaterial by UV radiation without degassing. J Biomed Mater Res. 1999;45:133–139.
- Tripathi SK, Ahmadi Z, Gupta KC, et al. Polyethylenimine-polyacrylic acid nanocomposites: type of bonding does influence the gene transfer efficacy and cytotoxicity. Colloids Surf B: Biointerfaces. 2016;140:117–120.
- Yuan L, Tang Q, Yang D, et al. Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery. J Phys Chem C. 2011;115: 9926–9932.
- Xiao X, Liu Y, Guo M, et al. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo. J Biomater Appl. 2016;31:23–35.
- Li H, Yu H, Zhu C, et al. Cisplatin and doxorubicin dual-loaded mesoporous silica nanoparticles for controlled drug delivery. RSC Adv. 2016;6:94160–94169.
- Saroj S, Rajput SJ. Etoposide encapsulated functionalized mesoporous silica nanoparticles: synthesis, characterization and effect of functionalization on dissolution kinetics in simulated and biorelevant media. J Drug Deliv Sci Technol. 2018;44:27--40.
- Shah PV, Rajput SJ. A comparative in vitro release study of raloxifene encapsulated ordered MCM-41 and MCM-48 nanoparticles: a dissolution kinetics study in simulated and biorelevant media. J Drug Deliv Sci Technol. 2017;41:31–44.
- Kettiger H, Québatte G, Perrone B, et al. Interactions between silica nanoparticles and phospholipid membranes. Biochimica Et Biophysica Acta (BBA)-Biomembranes. 2016;1858:2163–2170.
- Wouters BH, Chen T, Dewilde M, et al. Reactivity of the surface hydroxyl groups of MCM-41 towards silylation with trimethylchlorosilane. Microporous Mesoporous Mat. 2001;44: 453–457.
- Yoncheva K, Popova M, Szegedi A, et al. Functionalized mesoporous silica nanoparticles for oral delivery of budesonide. J Solid State Chem. 2014;211:154–161.
- Kim JM, Chang SM, Kong SM, et al. Control of hydroxyl group content in silica particle synthesized by the sol-precipitation process. Ceramics Int. 2009;35:1015–1019.
- Jaroniec C, Gilpin R, Jaroniec M. Adsorption and thermogravimetric studies of silica-based amide bonded phases. J Phys Chem B. 1997;101:6861–6866.
- Sing KS. Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Recommendations 1984). Pure Appl Chem. 1985;57:603–619.
- Bruschi ML. Strategies to modify the drug release from pharmaceutical systems. Canada: Woodhead Publishing; 2015; (1):37–62.
- Jin S, Liu M, Chen S, et al. A drug-loaded gel based on polyelectrolyte complexes of poly (acrylic acid) with poly (vinylpyrrolidone) and chitosan. Mat Chem Phys. 2010;123:463–470.
- Daryasari MP, Akhgar MR, Mamashli F, et al. Chitosan-folate coated mesoporous silica nanoparticles as a smart and pH-sensitive system for curcumin delivery. RSC Adv. 2016;6: 105578–105588.
- Li J, Zheng L, Cai H, et al. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging. Biomaterials. 2013;34:8382–8392.
- Finlay J, Roberts CM, Dong J, et al. Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden. Nanomed: Nanotechnol Biol Med. 2015;11:1657–1666.
- Charnay C, Bégu S, Tourné-Péteilh C, et al. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur J Pharm Biopharm. 2004;57:533–540.